NDC 72603-221-01 - Ampicillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72603-221
- Requested NDC
- 72603-221-01
- Package NDCs from labels
- 72603-221-01, 72603-221-10
- Manufacturer
- NorthStar Rx, LLC | Istituto Biochimico Italiano Giovanni Lorenzini
- Effective date
- 2024-02-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ampicillin - NorthStar Rx, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | NorthStar Rx, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | 2024-02-22 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72603-221-01 | Ampicillin | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 1 | |
| 72603-221-10 | Ampicillin | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72603-221-01 | EA - Each | 72603-221 | f0303a72-faa3-4ab3-aa5a-167ad3dd7f13 | 1 | 2024-07-12 |
| 72603-221-10 | EA - Each | 72603-221 | 3bfcd13c-11e7-4c15-90eb-7612e3dea337 | 1 | 2024-07-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | c4310ee5-cbd3-99b5-e053-2995a90ae229 | 2023-04-27 | Warnings, Adverse reactions | 1721475 JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Fresenius Kabi USA, LLC | 8dbb4c71-8543-08f1-e053-2995a90af88d | 2022-10-21 | Warnings, Adverse reactions | ANDA062797 ANDA062719 1721474 1721475 1721476 JFN36L5S8K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.